fibromyalgia glp 1 Ep 181 Exploring GLP-1 Agonists as a treatment option for Weight Loss and Chronic Pain - Conquering Your Podcast Has anyone used GLP-1 for

Diabetes is prevalent worldwide and the number of patients is drastically rising, with a predication of 366 million in 2030 due to factors such as obesity, inactivity,

This guide explores the key differences, benefits, and considerations to help

d-Chiro-inositol is a natural molecule that, in association with its well-studied isomer myo-inositol, may play a role in treating various metabolic and gynecological disorders

Bottom line: GLP-1s opened the door by proving obesity therapies can be CV disease interventions

Limitations The major limitations of the studies that are included in this systematic review are the enrollment of healthy subjects and insufficient data in conditions that might affect pharmacokinetics (e.g., kidney dysfunction)

we hope this guide, written by academics, consultants, GPs and a patient with lived experience will help you to prescribe safely particularly in primary care: don't forget to think about the risks with polypharmacy as people lose weight, the return of fertility, risks and side effects, masked malignant weight loss, the risks of malnutrition in obesity (particularly for those who struggle to afford nutritious food) enquire about what people are actually eating (rather than just about caloric reduction or weight lost): "when did you last eat a green leafy vegetable?", "what did you have for breakfast/lunch/dinner yesterday?", "what are you drinking?" are good enough screeners for most people in short consultations: *dietary quality matters* British Society of Lifestyle Medicine Royal College of General Practitioners Sarah Le Brocq Dr Laurence Dobbie Barbara McGowan Dipesh C